Company intelligence / Profile preview
Tasly
Rockville, Maryland, United States
- Ownership
- Private
- Employees
- ~10000
- Development stage
- Other
01
Overview
Tasly's lead botanical drug T89 (Dantonic) completed global Phase III trials for chronic stable angina and is approved in 24 countries (not the USA); the pipeline includes compounds at various stages up to Phase III, with oncology and cardiovascular focus. Investigational cancer small molecules (TSL1502) are in Phase II in China, a polypeptide antiviral (HEPA44) is applying for US IND, and a stem cell program completed Phase I.
- Therapeutic areas
- EndocrinologyInfectious DiseasesPulmonologyCardiovascularOncologyNeurology
- Modalities
- Herbal medicineSmall moleculePolypeptideStem cell therapyBiologic
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Planned joint venture with Herbalife (announced 2017)Academic, hospital, and pharma company collaborations (various, not all public)
Beyond the preview
Go deeper on Tasly.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tasly.